RECRUITING

Dietary Monosaccharide Supplementation in Patients With Congenital Disorders of Glycosylation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Researchers are trying to assess whether the use of simple sugars given as a daily dietary supplement can improve the health of children with congenital disorders of glycosylation (CDG).

Official Title

Dietary Monosaccharide Supplementation in Patients With Congenital Disorders of Glycosylation

Quick Facts

Study Start:2018-12-06
Study Completion:2024-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04198987

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:Not specified
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Not specified
Standard Ages:CHILD, ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Patient has a biochemically and genetically proven congenital disorder of glycosylation
  2. * Patient is receiving (or planning to receive) oral simple sugar supplementation
  1. * Aldolase B deficiency
  2. * Galactosemia
  3. * Hemolytic uremic syndrome
  4. * Severe anemia
  5. * Galactose intolerance

Contacts and Locations

Study Contact

David Deyle, M.D.
CONTACT
507-293-5864
Deyle.David@mayo.edu
Bryce Kuschel, M.S.
CONTACT
507-266-9140
kuschel.bryce@mayo.edu

Principal Investigator

David Deyle, MD
PRINCIPAL_INVESTIGATOR
Mayo Clinic

Study Locations (Sites)

Mayo Clinic in Rochester
Rochester, Minnesota, 55905
United States

Collaborators and Investigators

Sponsor: Mayo Clinic

  • David Deyle, MD, PRINCIPAL_INVESTIGATOR, Mayo Clinic

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2018-12-06
Study Completion Date2024-12

Study Record Updates

Study Start Date2018-12-06
Study Completion Date2024-12

Terms related to this study

Additional Relevant MeSH Terms

  • Congenital Disorder of Glycosylation